Thomas Richard Kassberg, CBO & Senior Vice President at Ultragenyx Pharmaceutical Inc. (RARE), sold 3,333 shares at $54.31 ($181K) on 2015-02-11, disclosed to the SEC on 2015-02-13.
Scheduled sale ($181k) by CBO & Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RARE | SELL | 2024-03-05 | $109K | — | Filing → |
| RARE | SELL | 2023-10-24 | $2.6M | — | Filing → |
| RARE | SELL | 2023-03-03 | $178K | — | Filing → |